The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amphotericin B Liposome for Injection Market Research Report 2025
Synopsis
Amphotericin B Liposome for Injection is a antifungal liposomal formulation. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B Liposome for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Amphotericin B Liposome for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amphotericin B Liposome for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amphotericin B Liposome for Injection include Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amphotericin B Liposome for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B Liposome for Injection.
The Amphotericin B Liposome for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Amphotericin B Liposome for Injection market comprehensively. Regional market sizes, concerning products by Specification, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amphotericin B Liposome for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Specification, by Application, and by regions.
By Company
Gilead Sciences
SPH New Asia Pharmaceuticals
Jemincare
Segment by Specification
2mg
10mg
50mg
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amphotericin B Liposome for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amphotericin B Liposome for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amphotericin B Liposome for Injection is a antifungal liposomal formulation. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B Liposome for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Amphotericin B Liposome for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Amphotericin B Liposome for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Amphotericin B Liposome for Injection include Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amphotericin B Liposome for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B Liposome for Injection.
The Amphotericin B Liposome for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Amphotericin B Liposome for Injection market comprehensively. Regional market sizes, concerning products by Specification, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amphotericin B Liposome for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Specification, by Application, and by regions.
By Company
Gilead Sciences
SPH New Asia Pharmaceuticals
Jemincare
Segment by Specification
2mg
10mg
50mg
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amphotericin B Liposome for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amphotericin B Liposome for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Specification, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amphotericin B Liposome for Injection Market Overview
1.1 Product Definition
1.2 Amphotericin B Liposome for Injection by Specification
1.2.1 Global Amphotericin B Liposome for Injection Market Value Comparison by Specification (2024-2030)
1.2.2 2mg
1.2.3 10mg
1.2.4 50mg
1.3 Amphotericin B Liposome for Injection by Application
1.3.1 Global Amphotericin B Liposome for Injection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Amphotericin B Liposome for Injection Market Size Estimates and Forecasts
1.4.1 Global Amphotericin B Liposome for Injection Revenue 2019-2030
1.4.2 Global Amphotericin B Liposome for Injection Sales 2019-2030
1.4.3 Global Amphotericin B Liposome for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amphotericin B Liposome for Injection Market Competition by Manufacturers
2.1 Global Amphotericin B Liposome for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amphotericin B Liposome for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amphotericin B Liposome for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Amphotericin B Liposome for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amphotericin B Liposome for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amphotericin B Liposome for Injection, Product Type & Application
2.7 Global Key Manufacturers of Amphotericin B Liposome for Injection, Date of Enter into This Industry
2.8 Global Amphotericin B Liposome for Injection Market Competitive Situation and Trends
2.8.1 Global Amphotericin B Liposome for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amphotericin B Liposome for Injection Players Market Share by Revenue
2.8.3 Global Amphotericin B Liposome for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amphotericin B Liposome for Injection Market Scenario by Region
3.1 Global Amphotericin B Liposome for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amphotericin B Liposome for Injection Sales by Region: 2019-2030
3.2.1 Global Amphotericin B Liposome for Injection Sales by Region: 2019-2024
3.2.2 Global Amphotericin B Liposome for Injection Sales by Region: 2025-2030
3.3 Global Amphotericin B Liposome for Injection Revenue by Region: 2019-2030
3.3.1 Global Amphotericin B Liposome for Injection Revenue by Region: 2019-2024
3.3.2 Global Amphotericin B Liposome for Injection Revenue by Region: 2025-2030
3.4 North America Amphotericin B Liposome for Injection Market Facts & Figures by Country
3.4.1 North America Amphotericin B Liposome for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amphotericin B Liposome for Injection Sales by Country (2019-2030)
3.4.3 North America Amphotericin B Liposome for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amphotericin B Liposome for Injection Market Facts & Figures by Country
3.5.1 Europe Amphotericin B Liposome for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amphotericin B Liposome for Injection Sales by Country (2019-2030)
3.5.3 Europe Amphotericin B Liposome for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amphotericin B Liposome for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Amphotericin B Liposome for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amphotericin B Liposome for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Amphotericin B Liposome for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Amphotericin B Liposome for Injection Market Facts & Figures by Country
3.7.1 Latin America Amphotericin B Liposome for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amphotericin B Liposome for Injection Sales by Country (2019-2030)
3.7.3 Latin America Amphotericin B Liposome for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Amphotericin B Liposome for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Amphotericin B Liposome for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amphotericin B Liposome for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amphotericin B Liposome for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Specification
4.1 Global Amphotericin B Liposome for Injection Sales by Specification (2019-2030)
4.1.1 Global Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
4.1.2 Global Amphotericin B Liposome for Injection Sales by Specification (2025-2030)
4.1.3 Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2030)
4.2 Global Amphotericin B Liposome for Injection Revenue by Specification (2019-2030)
4.2.1 Global Amphotericin B Liposome for Injection Revenue by Specification (2019-2024)
4.2.2 Global Amphotericin B Liposome for Injection Revenue by Specification (2025-2030)
4.2.3 Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2019-2030)
4.3 Global Amphotericin B Liposome for Injection Price by Specification (2019-2030)
5 Segment by Application
5.1 Global Amphotericin B Liposome for Injection Sales by Application (2019-2030)
5.1.1 Global Amphotericin B Liposome for Injection Sales by Application (2019-2024)
5.1.2 Global Amphotericin B Liposome for Injection Sales by Application (2025-2030)
5.1.3 Global Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2030)
5.2 Global Amphotericin B Liposome for Injection Revenue by Application (2019-2030)
5.2.1 Global Amphotericin B Liposome for Injection Revenue by Application (2019-2024)
5.2.2 Global Amphotericin B Liposome for Injection Revenue by Application (2025-2030)
5.2.3 Global Amphotericin B Liposome for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Amphotericin B Liposome for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Amphotericin B Liposome for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gilead Sciences Amphotericin B Liposome for Injection Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 SPH New Asia Pharmaceuticals
6.2.1 SPH New Asia Pharmaceuticals Company Information
6.2.2 SPH New Asia Pharmaceuticals Description and Business Overview
6.2.3 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product Portfolio
6.2.5 SPH New Asia Pharmaceuticals Recent Developments/Updates
6.3 Jemincare
6.3.1 Jemincare Company Information
6.3.2 Jemincare Description and Business Overview
6.3.3 Jemincare Amphotericin B Liposome for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jemincare Amphotericin B Liposome for Injection Product Portfolio
6.3.5 Jemincare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amphotericin B Liposome for Injection Industry Chain Analysis
7.2 Amphotericin B Liposome for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amphotericin B Liposome for Injection Production Mode & Process
7.4 Amphotericin B Liposome for Injection Sales and Marketing
7.4.1 Amphotericin B Liposome for Injection Sales Channels
7.4.2 Amphotericin B Liposome for Injection Distributors
7.5 Amphotericin B Liposome for Injection Customers
8 Amphotericin B Liposome for Injection Market Dynamics
8.1 Amphotericin B Liposome for Injection Industry Trends
8.2 Amphotericin B Liposome for Injection Market Drivers
8.3 Amphotericin B Liposome for Injection Market Challenges
8.4 Amphotericin B Liposome for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Amphotericin B Liposome for Injection Market Value Comparison by Specification (2024-2030) & (US$ Million)
Table 2. Global Amphotericin B Liposome for Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Amphotericin B Liposome for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amphotericin B Liposome for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amphotericin B Liposome for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amphotericin B Liposome for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amphotericin B Liposome for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amphotericin B Liposome for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amphotericin B Liposome for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amphotericin B Liposome for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amphotericin B Liposome for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Amphotericin B Liposome for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amphotericin B Liposome for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B Liposome for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amphotericin B Liposome for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amphotericin B Liposome for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Amphotericin B Liposome for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Amphotericin B Liposome for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Amphotericin B Liposome for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Amphotericin B Liposome for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amphotericin B Liposome for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Amphotericin B Liposome for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amphotericin B Liposome for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Amphotericin B Liposome for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Amphotericin B Liposome for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amphotericin B Liposome for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amphotericin B Liposome for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amphotericin B Liposome for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amphotericin B Liposome for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amphotericin B Liposome for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amphotericin B Liposome for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amphotericin B Liposome for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amphotericin B Liposome for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amphotericin B Liposome for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amphotericin B Liposome for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amphotericin B Liposome for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Amphotericin B Liposome for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Amphotericin B Liposome for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Amphotericin B Liposome for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amphotericin B Liposome for Injection Sales (K Units) by Specification (2019-2024)
Table 51. Global Amphotericin B Liposome for Injection Sales (K Units) by Specification (2025-2030)
Table 52. Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Table 53. Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2025-2030)
Table 54. Global Amphotericin B Liposome for Injection Revenue (US$ Million) by Specification (2019-2024)
Table 55. Global Amphotericin B Liposome for Injection Revenue (US$ Million) by Specification (2025-2030)
Table 56. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2019-2024)
Table 57. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2025-2030)
Table 58. Global Amphotericin B Liposome for Injection Price (US$/Unit) by Specification (2019-2024)
Table 59. Global Amphotericin B Liposome for Injection Price (US$/Unit) by Specification (2025-2030)
Table 60. Global Amphotericin B Liposome for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Amphotericin B Liposome for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Amphotericin B Liposome for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Amphotericin B Liposome for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amphotericin B Liposome for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amphotericin B Liposome for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Amphotericin B Liposome for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Amphotericin B Liposome for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Amphotericin B Liposome for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Amphotericin B Liposome for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Gilead Sciences Amphotericin B Liposome for Injection Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. SPH New Asia Pharmaceuticals Company Information
Table 76. SPH New Asia Pharmaceuticals Description and Business Overview
Table 77. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product
Table 79. SPH New Asia Pharmaceuticals Recent Developments/Updates
Table 80. Jemincare Company Information
Table 81. Jemincare Description and Business Overview
Table 82. Jemincare Amphotericin B Liposome for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Jemincare Amphotericin B Liposome for Injection Product
Table 84. Jemincare Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Amphotericin B Liposome for Injection Distributors List
Table 88. Amphotericin B Liposome for Injection Customers List
Table 89. Amphotericin B Liposome for Injection Market Trends
Table 90. Amphotericin B Liposome for Injection Market Drivers
Table 91. Amphotericin B Liposome for Injection Market Challenges
Table 92. Amphotericin B Liposome for Injection Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Amphotericin B Liposome for Injection
Figure 2. Global Amphotericin B Liposome for Injection Market Value Comparison by Specification (2024-2030) & (US$ Million)
Figure 3. Global Amphotericin B Liposome for Injection Market Share by Specification: 2023 & 2030
Figure 4. 2mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 50mg Product Picture
Figure 7. Global Amphotericin B Liposome for Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Amphotericin B Liposome for Injection Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Amphotericin B Liposome for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Amphotericin B Liposome for Injection Market Size (2019-2030) & (US$ Million)
Figure 14. Global Amphotericin B Liposome for Injection Sales (2019-2030) & (K Units)
Figure 15. Global Amphotericin B Liposome for Injection Average Price (US$/Unit) & (2019-2030)
Figure 16. Amphotericin B Liposome for Injection Report Years Considered
Figure 17. Amphotericin B Liposome for Injection Sales Share by Manufacturers in 2023
Figure 18. Global Amphotericin B Liposome for Injection Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Amphotericin B Liposome for Injection Players: Market Share by Revenue in Amphotericin B Liposome for Injection in 2023
Figure 20. Amphotericin B Liposome for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Amphotericin B Liposome for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2030)
Figure 23. North America Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2030)
Figure 24. United States Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2030)
Figure 27. Europe Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2030)
Figure 28. Germany Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Amphotericin B Liposome for Injection Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Amphotericin B Liposome for Injection Revenue Market Share by Region (2019-2030)
Figure 35. China Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2030)
Figure 43. Mexico Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Amphotericin B Liposome for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Amphotericin B Liposome for Injection by Specification (2019-2030)
Figure 53. Global Revenue Market Share of Amphotericin B Liposome for Injection by Specification (2019-2030)
Figure 54. Global Amphotericin B Liposome for Injection Price (US$/Unit) by Specification (2019-2030)
Figure 55. Global Sales Market Share of Amphotericin B Liposome for Injection by Application (2019-2030)
Figure 56. Global Revenue Market Share of Amphotericin B Liposome for Injection by Application (2019-2030)
Figure 57. Global Amphotericin B Liposome for Injection Price (US$/Unit) by Application (2019-2030)
Figure 58. Amphotericin B Liposome for Injection Value Chain
Figure 59. Amphotericin B Liposome for Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
